| Literature DB >> 24936390 |
Fabiola Luna-Vazquez1, Rosalía Cruz-Lumbreras2, Julia Rodríguez-Castelán1, Margarita Cervantes-Rodríguez3, Jorge Rodríguez-Antolín4, Omar Arroyo-Helguera5, Francisco Castelán4, Margarita Martínez-Gómez6, Estela Cuevas4.
Abstract
PURPOSE: To determine the association between the serum concentration of triiodothyronine (T3) with components of metabolic syndrome (MetS), cardiovascular risk (CVR), and diet in euthyroid post-menopausal women without and with MetS.Entities:
Keywords: Calorie intake; Cardiovascular risk; Hyperglycemia; Metabolic syndrome; Thyroid hormone; Thyrotropin
Year: 2014 PMID: 24936390 PMCID: PMC4041934 DOI: 10.1186/2193-1801-3-266
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Correlation analysis between TSH or thyroid hormones and cardio-metabolic variables in euthyroid post-menopausal women
|
|
|
|
|
|
|---|---|---|---|---|
| Age (years) | -0.061 | -0.205* | -0.036 | -0.205* |
| BMI (kg/m2) | -0.108 | 0.114 | 0.136 | 0.220* |
| Glucose (mg/dL) | -0.023 | -0.010 | 0.261* | -0.264** |
| Insulin (μUI/mL) | -0.099 | 0.046 | 0.030 | 0.425*** |
| HOMA-IR | -0.079 | 0.080 | 0.167 | 0.239** |
| Triglycerides (mg/dL) | 0.063 | 0.021 | 0.011 | -0.052 |
| Cholesterol (mg/dL) | -0.045 | -0.096 | -0.022 | -0.100 |
| HDL-C (mg/dL) | 0.113 | 0.034 | 0.084 | -0.266** |
| Systolic pressure (mmHg) | -0.038 | 0.067 | 0.136 | -0.072 |
| Diastolic pressure (mmHg) | 0.125 | 0.201* | 0.187* | -0.002 |
| Serum iodine (μg/L) | -0.548*** | 0.008 | 0.343* | 0.286* |
| Menarche (years) | -0.055 | -0.004 | -0.014 | 0.084 |
| Age of menopause (years) | 0.035 | -0.109 | -0.040 | -0.157 |
| Years post-menopause | -0.021 | -0.129 | -0.010 | -0.131 |
TSH, thyrotropin; T4, thyroxine; T3, triiodothyronine. BMI, body mass index; HOMA-IR, insulin resistance; high-density lipoprotein cholesterol (HDL-C). All participants (n = 120) were included for these analyses, except to the serum iodine in which only samples from 52 women were measured. Simple Pearson or Spearman correlation tests were applied. Values are correlation coefficients. *P ≤ 0.05, **P < 0.01, and ***P < 0.001.
Mean ± SD of thyrotropin (TSH), thyroid hormones, serum iodine, and cardio-metabolic variables in euthyroid post-menopausal women grouped according to the presence of metabolic syndrome (MetS) and triiodothyronine (T3) concentration
| Without MetS | MetS-T3Q1 | MetS-T3Q2 | MetS-T3Q3 | MetS-T3Q4 | Statistic K or F; P | |
|---|---|---|---|---|---|---|
| n = 33 | n = 22 | n = 21 | n =21 | n = 23 | ||
| TSH (μUI/mL) | 2.8 ± 2.1a | 2.5 ± 1.4a | 2.3 ± 1.5a | 2.6 ± 1.9a | 2.4 ± 1.8a | Ns |
| T4 (μg/mL) | 8.9 ± 0.4ab | 8.2 ± 1.1b | 8.4 ± 1.5ab | 9.7 ± 1.1a | 9.4 ± 1.2a | 4.0; 0.002 |
| Free T4 (μg/mL) | 1.1 ± 0.2 | 1.1 ± 0.1 | 1.1 ± 0.1 | 1.1 ± 0.2 | 1.1 ± 0.1 | Ns |
| T3 (μg/mL) | 1.2 ± 0.2ac | 0.9 ± 0.1b | 1.1 ± 0.04a | 1.2 ± 0.06c | 1.4 ± 0.1d | 62.9; <0.0001 |
| Range of T3 concentration (μg/mL) | (0.81-1.47) | (0.66-0.99) | (0.10-1.13) | (1.14-1.33) | (1.34-1.70) | |
| Age (years) | 67.4 ± 11.8 | 70.8 ± 8.6 | 68.9 ± 10.4 | 66.3 ± 7.5 | 64.9 ± 10.5 | Ns |
| BMI (kg/m2) | 25.1 ± 5.3a | 24.4 ± 3.8a | 26.6 ± 3.5ab | 26.8 ± 3.0ab | 28.6 ± 5.0b | 14.9; 0.004 |
| Glucose (mg/dL) | 100.6 ± 30.6a | 133.7 ± 47.5bc | 158.0 ± 58.9c | 135.5 ± 56.0bc | 109.7 ± 57.5ab | 28.5; <0.0001 |
| Insulin (μUI/mL) | 9.2 ± 5.8a | 8.8 ± 8.6a | 10.0 ± 6.5a | 12.6 ± 6.6ab | 16.4 ± 7.0b | 27.1; <0.0001 |
| HOMA-IR | 2.2 ± 1.4a | 3.1 ± 3.4ab | 3.6 ± 1.8abc | 4.3 ± 3.0bc | 4.4 ± 2.0c | 25.5; <0.0001 |
| HDL-C (mg/dL) | 51.0 ± 19.3a | 44.4 ± 9.6ab | 48.7 ± 30.0ab | 40.1 ± 6.0b | 39.7 ± 10.0ab | 12.0; 0.01 |
| Cholesterol (mg/dL) | 198.5 ± 6.2 | 215.5 ± 13.6 | 197.9 ± 8.5 | 183.8 ± 9.3 | 195.6 ± 7.7 | Ns |
| Systolic pressure (mmHg) | 118.2 ± 3.1a | 125.5 ± 3.2ab | 133.3 ± 3.9b | 124.3 ± 2.9ab | 129.6 ± 2.9ab | 12.3; 0.01 |
| Diastolic pressure (mmHg) | 73.6 ± 1.6 | 73.1 ± 1.5 | 73.3 ± 2.4 | 74.7 ± 2.4 | 75.7 ± 1.8 | Ns |
T4, thyroxine; BMI, body mass index; HOMA-IR, insulin resistance index; high-density lipoprotein cholesterol (HDL-C). ANOVA or Kruskal-Wallis tests and Tukey-Kramer or Dunns post-hoc test were applied. Ns: no significant. Different letters indicate statistical differences between groups reported by post-hoc tests.
Percentage and odds ratios (CI 95%) for metabolic syndrome (MetS) components and cardiovascular risk (CVR) in euthyroid post-menopausal women grouped considering the presence of MetS and triiodothyronine (T3) concentration
| Without MetS n=33 | MetS-T3Q1 n=22 | MetS-T3Q2 n=21 | MetS-T3Q3 n=21 | MetS-T3Q4 n=23 | |
|---|---|---|---|---|---|
| Waist circumference | 30.3% | 45.5% | 66.7% | 85.7% | 82.6% |
| REF | 2.8 (0.8-9.7) | 6.4 (1.7-23.5)** | 16.2 (3.6-72.8)*** | 12.7 (3.0-53.3)*** | |
| Arterial tension | 30.3% | 72.7% | 81.0% | 61.9% | 69.5% |
| REF | 5.7 (1.6-19.2)** | 10.0 (2.6-38.6)*** | 4.1 (1.2-13.3)* | 6.2 (1.8-21.0)** | |
| Hyperglycemia | 27.3% | 95.5% | 85.7% | 66.7% | 65.2% |
| REF | 53.8 (6.2-462.2)*** | 15.8 (3.7-67.4)*** | 5.4 (1.6-18.1)** | 5.2 (1.6-16.9)** | |
| Triglycerides | 24.2% | 72.7% | 52.4% | 57.1% | 65.2% |
| REF | 8.0 (2.3-27.8)** | 3.3 (1.0-10.9)* | 4.2 (1.3-13.7)* | 6.0 (1.8-19.6)** | |
| Low HDL-C | 54.5% | 76.2%(21) | 76.2% | 95.2% | 85.7% (21) |
| REF | 2.8 (0.8-9.5) | 2.7 (0.8-9.2) | 16.4 (1.9-137.6)* | 4.9 (1.2-20.0)* | |
| HOMA-IR | 24.2% | 36.3% | 66.7% | 66.7% | 78.2% |
| REF | 2.4 (0.6-8.5) | 8.3 (2.2-30.5)*** | 6.8 (1.9-24.2)** | 12.3 (3.2-47.1)*** | |
| CVR moderate/high | 6.1% | 45.5%(21) | 52.4% | 47.6% | 19.0%(21) |
| REF | 14.6 (2.7-78.6)*** | 17.4 (3.2-92.9)*** | 14.0 (2.6-74.3)** | 3.5 (0.5-21.7) |
Binomial logistic regression was applied adjusting age was for all cases. HDL-C, HDL cholesterol; HOMA-IR, insulin resistance. *P ≤ 0.05, **P < 0.01, and ***P < 0.001. Note: HDL-C was not possible to be measure for all women. Numbers into superscript parenthesis together to prevalence for groups MetS-T3Q1 and MetS-T3Q4 indicate the number of participants for HDL-C and CVR.
Means ± SD of dietetic variables, percentage of dietetic deficiencies, and odds ratio (OR) of dietetic alterations for euthyroid post-menopausal women considering the presence of metabolic syndrome (MetS) and triiodothyronine (T3) concentrations
| Without MetS n=29 | MetS-T3Q1 n=20 | MetS-T3Q2 n=16 | MetS-T3Q3 n=18 | MetS-T3Q4 n=19 | Statistic K or F; P; χ2; P | |
|---|---|---|---|---|---|---|
| Caloric intake (kcal/day) | 1401.1 ± 514.3 | 1217.8 ± 380.1 | 1301.2 ± 500.3 | 1310.4 ±300.1 | 1584.7 ± 598.7 | Ns |
| Low calories intake <1600 Kcal/day | 69%a | 95%b | 68.8%ab | 83.3%ab | 52.6%a | 10.3; 0.03 |
| OR (CI 95%) for low calories intake without age adjusted | REF | 8.5 (0.9-74.0)* | 0.9 (0.2-3.6) | 2.2 (0.5-9.7) | 0.5 (0.1-1.6) | |
| OR (CI 95%) for low calories intakeǂ | REF | 7.3 (0.8-65.8)┼ | 1.0 (0.2-4.0) | 2.3 (0.5-10.6) | 0.5 (0.1-2.0) | |
| Protein intake (g/day) | 50.8 ± 20.4 | 46.8 ± 16.0 | 51.7 ± 19.7 | 49.4 ± 16.6 | 63.7 ± 28.7 | Ns |
| Low protein intake (range 10-35%) | 6.9% | 5% | 12.5% | 5.5% | 0.0% | Ns |
| OR (CI 95%) for low protein intakeǂ | REF | 0.6 (0.05-7.9) | 1.9 (0.2-16.1) | 0.7 (0.6-9.7) | NA | |
| Lipid intake (g/day) | 36.31 ± 24.9 | 31.6 ± 17.9 | 30.4 ± 15.8 | 34.8 ± 15.6 | 42.6 ± 27.7 | Ns |
| Low lipid intake (range 20-35%) | 48.3% | 35.0% | 43.8% | 22.2% | 31.5% | Ns |
| OR (CI 95%) for low lipid intakeǂ | REF | 0.5 (0.1-1.8) | 1.0 (0.2-3.6) | 0.3 (0.09-1.4) | 0.8 (0.2-3.1) | |
| Carbohydrate intake (g/day) | 218.4 ± 71.5 | 186.6 ± 64.1 | 205.3 ± 101.5 | 200.4 ± 49.6 | 236.7 ± 74.4 | Ns |
| High carbohydrate intake (range 45-65%) | 44.8% | 25.0% | 25.0% | 22.2% | 26.3% | Ns |
| OR (CI 95%) for high carbohydrate intakeǂ | REF | 0.4 (0.1-1.4) | 0.4 (0.1-1.8) | 0.4 (0.1-1.5) | 0.6 (0.1-2.4) | |
| Fiber (g/day) | 15.2 ± 5.6 | 14.2 ± 6.6 | 15.0 ± 4.2 | 14.5 ± 3.3 | 18.7 ± 5.9 6 | Ns |
| Low fiber intake <22 g/day | 86.2% | 85.0% | 93.8% | 100% | 8.4% | Ns |
| Calcium (mg/day) | 991.2 ± 443.9 | 909.8 ± 333.0 | 1071.5 ± 488.1 | 909.9 ± 326.1 | 1227.6 ± 589.9 | Ns |
| Low calcium intake <1200 mg/day | 69.0% | 80.0% | 68.8% | 88.9% | 52.6% | Ns |
| Sodium (mg/day) | 1418.5 ± 581.6 | 1333.1 ± 577.8 | 1379.8 ± 411.3 | 1405.5 ± 328.9 | 1735.4 ± 578.5 | Ns |
| High sodium intake <2300 mg/day | 10.3% | 10.0% | 6.3% | 0.0% | 15.7% | Ns |
| Phosphorous (mg/day) | 761.3 ± 301.1 | 680.7 ± 217.0 | 810.2 ± 432.7 | 737.4 ± 229.8 | 885.9 ± 329.4 | Ns |
| Low phosphorous intake <700 mg/day | 48.3% | 65.0% | 37.5% | 50.0% | 36.0% | Ns |
| Iron (mg/day) | 31.2 ± 10.3ab | 28.6 ± 12.2a | 31.1 ± 8.4ab | 29.3 ± 6.3 ab | 38.3 ± 12.5b | 2.6; 0.03 |
| Low iron intake <8 mg/day | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | Ns |
| Selenium (mg/day) | 25.8 ± 23.7 | 25.2 ± 20.6 | 33.3 ± 24.3 | 25.7 ± 19.9 | 37.6 ± 25.1 | Ns |
| Low selenium intake <55 mg/day | 82.8% | 95.0% | 75.0% | 83.3% | 63.1% | Ns |
| Ascorbic acid (mg/day) | 30.1 ± 31.7 | 46.1 ± 72.3 | 35.2 ± 28.5 | 28.0 ± 33.5 | 29.6 ± 13.8 | Ns |
| Low ascorbic acid intake <75 mg/day | 89.7% | 90.0% | 93.8% | 94.4% | 100.0% | Ns |
| Vitamin A (μg ER/day) | 621.8 ± 476.1 | 615.7 ± 338.4 | 752.8 ± 462.2 | 605.8 ± 324.2 | 768.4 ± 352.9 | Ns |
| Low vitamin A intake <700 mg/day | 62.1% | 65.0% | 50.0% | 61.1% | 47.3% | Ns |
| Vitamin E (mg/day) | 4.2 ± 3.3 | 6.3 ± 4.5 | 4.9 ± 2.5 | 6.0 ± 3.9 | 5.6 ± 3.1 | Ns |
| Low vitamin E intake <15 mg/day | 100.0% | 95.0% | 100.0% | 100.0% | 100.0% | Ns |
| Folate (mcg/day) | 71.0 ± 76.1 | 91.0 ± 88.1 | 66.3 ± 68.8 | 67.0 ± 79.6 | 70.5 ± 32.9 | Ns |
| Low folate intake <400 mcg/day | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | Ns |
Note: Diet survey was applied to 102 women. ANOVA or Kruskal-Wallis tests and Tukey-Kramer or Dunn’s post-hoc tests, and chi-square were applied. ǂBinomial regression analysis (age and BMI adjusted) were done for macronutrients. Ns: no significant. Different letters indicate statistical differences between groups reported by post-hoc tests. *P = 0.05; ┼P = 0.07.